Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics? is a research paper published in Journal of Personalized Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01NS115139-03
Biomarkers of cognitive decline in Parkinson's Disease
National Institutes of Health
Grant: 5U19AG062418-02
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
National Institutes of Health
Grant: 3P30AG010124-28S1
Alzheimer's Disease Core Center - Neuroimaging Core I
Fields of Study
Keywords
Sustainable Development Goals